Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nisshin Pharma is a prominent Japanese healthcare company and a core subsidiary of the Nisshin Seifun Group. The company is globally recognized as a pioneer in the industrial production of Coenzyme Q10 and is a leading supplier of high-purity Vitamin B12. Its business operations encompass the development and manufacture of active pharmaceutical ingredients (APIs), health supplements, and functional food ingredients. Nisshin Pharma maintains multiple GMP-certified facilities in Japan, offering comprehensive contract manufacturing services including softgel encapsulation and granulation. The company's research focuses on leveraging fermentation and water-solubilization technologies to enhance the bioavailability of nutritional compounds for aging and cardiovascular health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nisshin Pharma.